Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) price on Wednesday, April 30, fall -15.01% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.26.
A look at the stock’s price movement, the close in the last trading session was $0.30, moving within a range at $0.237 and $0.276. The beta value (5-Year monthly) was 0.155. Turning to its 52-week performance, $4.00 and $0.17 were the 52-week high and 52-week low respectively. Overall, CYCC moved -7.52% over the past month.
Cyclacel Pharmaceuticals Inc’s market cap currently stands at around $98.43 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-01.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CYCC is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend CYCC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CYCC’s current price about 9.99% and -8.96% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 50.00, while 7-day volatility ratio is 41.41% and 19.25% in the 30-day chart. Further, Cyclacel Pharmaceuticals Inc (CYCC) has a beta value of 0.50, and an average true range (ATR) of 0.05. Analysts have given the company’s stock an average 52-week price target of $1, forecast between a low of $1 and high of $1. Looking at the price targets, the low is -284.62% off current price level while to achieve the yearly target high, price needs to move -284.62%. Nonetheless, investors will most likely welcome a -284.62% jump to $1 which is the analysts’ median price.
If we refocus on Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC), historical trading data shows that trading volumes averaged 13.03 over the past 10 days and 2.28 million over the past 3 months. The company’s latest data on shares outstanding shows there are 207.34 million shares.
The 93.87% of Cyclacel Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 0.34% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 27619.0 on 2025-04-15, giving us a short ratio of 0.16. The data shows that as of 2025-04-15 short interest in Cyclacel Pharmaceuticals Inc (CYCC) stood at 22.0 of shares outstanding, with shares short falling to 53583.0 registered in 2025-03-14. Current price change has pushed the stock -31.33% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CYCC stock continues to rise going into the next quarter.
